Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adaptive Radiation for Abdominopelvic Metastases (ARAM)

NCT05880667 is registered in ClinicalTrials.gov with Fox Chase Cancer Center as lead sponsor.

NCT NCT05880667
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05880667 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adaptive Radiation for Abdominopelvic Metastases (ARAM)
Lead sponsor
Fox Chase Cancer Center
Phase
Phase 1
Overall status
Recruiting
Start date
August 1, 2023
Completion date
June 1, 2029
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant neoplasm of stomach, neoplasm - soft tissue pelvis malignant secondary